moa of glp 1 agonists GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 receptor agonists (GLP-1RAs): cardiovascular

While the opportunity for oral GLP-1s is substantial, realising its full potential will depend on how effectively pharmaceutical companies and CDMOs navigate the associated challenges

Glucagon-like peptide-1, or GLP-1, is a hormone your body naturally produces, mainly in your gut, in response to eating

Common Side Effects: Oily spotting, gas with discharge, urgent bowel movements, and fatty stools

Rhee SY, Han KD, Kwon H, et al

Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Lee's team found that over the three years of the study, GLP-1 prescriptions among people ages 12 to 25 jumped by more than 594% (equivalent to a nearly sevenfold rise)